↑	increase(d)
↓	decrease(d)
∆	changed
=	unaltered
≠	different/altered
⊣	block
[]i	intracellular concentration
[]e	extracellular concentration
4-AP	4-aminopyride
ADME	absorption-distribution-metabolism-excretion
ADSHE	autosomal dominant sleep-related hypermotor epilepsy
AD(D/T)	after discharge (duration/threshold)
AED	anti-epileptic drug
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
AQP	aquaporin; ATP, adenosine triphosphate
BBB	blood-brain barrier
BLA	basolateral amygdala
CA	cornu ammonis
CBX	carbenoxolone
CL	cytoplasmic loop
CNS	central nervous system
CRP	c-reactive protein
CT	C-terminal tail
CT9	last nine amino acids of CT
Cx(43)	connexin (43)
D	days
dKO	double knock-out
EAAT	excitatory amino acid transporter
ECoG	electrocorticogram
EEG	electroencephalogram
EL	extracellular loops
EM	electromyogram
EPSC	excitatory postsynaptic current
ER	endoplasmic reticulum
FCD	focal cortical dysplasia
FRAP	fluorescence recovery after photobleaching
GABA	gamma-aminobutyric acid
GAERS	genetic absence epileptic rats from Strasbourg
GEPRS	genetically epilepsy prone rats ILA, ictal-like activity
GFAP	glial fibrillary acidic protein
GJ	gap junction
GJIC	gap junctional intercellular communication
GLAST	glutamate aspartate transporter
GLT1	glutamate transporter 1
GLUT-1	glucose transporter 1
GS	glutamine synthetase; h, hours
HIV-1	human immunodeficiency virus-1
HS	hippocampal sclerosis
HT	hyperthermia
IL-(1β; 6)	interleukin (1-beta; 6
i.c.v.	intracerebroventricular(ly)
i.p.	intraperitoneal(ly)
IP3	inositol trisphosphate
i.v.	intravenous(ly)
KA	kainic acid
Kir	inward rectifying K+ channel; KO, knock-out
LPS	lipopolysaccharide
M	months
MAPK	mitogen-activated protein kinase
MCP-1	monocyte chemoattractant protein 1
MES	maximal electroshock
Mf	mirror focus
MTLE	mesial temporal lobe epilepsy
NER	non-epileptic rat
NMDA	N-methyl-D-aspartate
NRT	nucleus reticularis thalami
NT	N-terminal tail
ODDD	oculodentodigital dysplasia
OMIM	Online Mendelian Inheritance in Man
P0	non-phosphorylated isoform
P(1/2)	phosphorylated isoform (1/2)
PAD	primary after discharge
Panx	pannexin
Pf	primary focus
PD	post-natal day
PTZ	pentylenetetrazol
S5(D)	seizure stage 5 (duration)
s.c.	subcutaneous(ly)
SE	status epilepticus
SH3	Src homology 3 domain of CT
SLE	seizure-like event; SV2A, synaptic vesicle protein 2A
SWD	spike-wave discharge
TAT	transactivator of transcription
TGF-β	transforming growth factor beta
TLE	temporal lobe epilepsy
TM	transmembrane
TNF-α	tumor necrosis factor α
VPL	nucleus ventralis posterolateralis
W	week